Allarity Therapeutics, Inc.
ALLR- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001860657
No open-market purchases or sales by Allarity Therapeutics, Inc. insiders were filed in the last 90 days; 20 institutions reported holding it in 13F filings for Q2 2026, worth $1.65M in total; no superinvestor holds it.
Key figures
- Insider buysOpen market, last 90 days
- 0
- Insider sellsOpen market, last 90 days
- 0
- 13F holdersQ2 2026, +6 vs. previous quarter
- 20
- 13F valueReported value at the end of Q2 2026
- $1.65M
- Superinvestors holdingAt the end of Q2 2026
- 0
Price chart
Superinvestors holding ALLR, Q2 2026
No superinvestor reported holding ALLR at the end of Q2 2026.
Latest insider trades
Open-market purchases and sales by Allarity Therapeutics, Inc. insiders from Form 4, newest first.
No open-market purchases or sales by Allarity Therapeutics, Inc. insiders are on file.
Top 10 13F holders, Q2 2026
The largest institutional positions in Allarity Therapeutics, Inc. at the end of Q2 2026; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Renaissance Technologies LLC | 331,509 | $427.6K | 0.00% | +103,425+45.3% | Added |
| Vanguard Capital Management LLC | 171,795 | $221.6K | 0.00% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 154,867 | $199.8K | 0.00% | −35,526−18.7% | Reduced |
| State Street Corp | 137,600 | $177.5K | 0.00% | 00.0% | Unchanged |
| Militia Capital Management LLC | 98,978 | $127.7K | 0.02% | +98,978 | New |
| Citadel Advisors LLC | 91,748 | $118.4K | 0.00% | +91,748 | New |
| Vanguard Fiduciary Trust Co | 74,913 | $96.6K | 0.00% | 00.0% | Unchanged |
| Northern Trust Corp | 36,534 | $47.1K | 0.00% | −11,569−24.1% | Reduced |
| HRT Financial LP | 37,003 | $47.0K | 0.00% | +37,003 | New |
| Jane Street Group, LLC | 36,021 | $46.5K | 0.00% | +36,021 | New |